Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Angiogenesis in Multiple Myeloma
TL;DR: The role of host cells or the niche microenvironment and extracellular matrix represents an intense area of research, finalized at a better understanding of the pathophysiological modifications of the complete tumor entity, i.e. malignant cells and microenvironment.
47
Antiangiogenic strategies in neuroblastoma.
Domenico Ribatti,Mirco Ponzoni +1 more
TL;DR: An overview of recent advances in antiangiogenesis in neuroblastoma is presented and the most important active substances, preclinical and clinical data, as well as future perspectives are described.
47
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
TL;DR: The number of tryptase-positive MC did not reflect findings representative of tumor mass when genomic aberrations are independent predictors of disease progression in early B-cell CLL, and these curves were plotted according to Kaplan–Meier, and compared with the log-rank test.
46
αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers
Mirella Belleri,Domenico Ribatti,Monica Savio,Lucia Anna Stivala,Luca Forti,Elena Tanghetti,Patrizia Alessi,Daniela Coltrini,Antonella Bugatti,Stefania Mitola,Stefania Nicoli,Vanio Vannini,Marco Presta +12 more
TL;DR: Stereoisomery affects the antiangiogenic activity of resveratrol, the trans isomer being significantly more potent than the cis isoform, which may have profound implications for the design of synthetic antiangIogenic/angiopreventive phytoalexin derivatives.
46
TNP‐470 and recombinant human interferon‐α2a inhibit angiogenesis synergistically
M Minischetti,Angelo Vacca,Domenico Ribatti,Monica Iurlaro,Roberto Ria,Antonio Pellegrino,Giampietro Gasparini,And Franco Dammacco +7 more
TL;DR: Experiments in vivo with the chick embryo chorioallantoic membrane (CAM)–sponge assay revealed the same dose‐dependent inhibition and synergy as in vitro, as the basic fibroblast growth factor (bFGF)‐induced angiogenesis in the CAM-sponge model was strongly inhibited by the combined treatment.
45